

Mum, ju hua, chu hua
Derived from the flower and aerial parts of the plant, Chrysanthemum is used frequently in traditional Chinese medicine to treat hypertension, angina, and fever. In vitro and animal studies indicate cytotoxic (10), anti-inflammatory, antipyretic (1) and neuroprotective (9) (11) properties. Chrysanthemum has not been subjected to clinical trials.
Hypersensitivity and photosensitivity reactions have been documented (2) (3).
Chrysanthemum is one of the eight components of PC-SPES.
Chrysanthemum increases coronary vasodilatation and coronary blood flow, but has little effect on cardiac contractility or oxygen consumption. It reduces the capillary permeability induced by histamine and operates as an antibacterial and antipyretic agent (1). Some studies indicate that chrysanthemum may have cytotoxic (4) (5) and antibacterial (6) properties. Extracts of chrysanthemum showed no effect on insulin levels (7).
A study done in rats showed that Luteolin and Apigenin reached the peak level at 1.1 and 3.9 hours following oral administration of 200mg/kg of Chrysanthemum morifolium extract (CME). Both the comounds were completely excreted in 72 hours after ingestion of CME.
(8)
May cause photosensitivity.
Patients with allergy to ragweed should avoid this herb.
Antihypertensive drugs: Theoretically, chrysanthemum may have an additive hypotensive effect.
Blood pressure
No clinical studies have been performed with chrysanthemum on humans.
Bottom Line: Chrysanthemum has not been shown to treat or prevent cancer.
Chrysanthemum has been used in traditional Chinese medicine for centuries, but very little laboratory research has been conducted. It is thought that the flower causes dilation of the coronary arteries and therefore increases blood flow to the heart, but this effect has not been clearly documented in humans. The mechanism underlying its anti-inflammatory, antibacterial, and fever-reducing activities is not known. Some studies indicate that chrysanthemum extracts can kill cancer cells in the laboratory setting, but it is not known whether this effect occurs in the human body.
No clinical studies have tested chrysanthemum in humans. Chrysanthemum is one of the components in PC-SPES, which has been used against prostate cancer in clinical trials.